Diabetes technology and therapeutics 影响因子
WebJan 19, 2024 · New clinical guidelines on diabetes technology. 19th January 2024. The latest guidance on the use of insulin pumps, continuous glucose monitoring and other technology in diabetes care was presented at December’s World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, as Dr Susan Aldridge reports. Web《糖尿病技术与治疗》(Diabetes Technology & Therapeutics)是一本以医学-内分泌学与代谢综合研究为特色的国际期刊。该刊由MARY ANN LIEBERT, INC出版商创刊于1999年，刊期Monthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-内分泌学与代谢领域的重点研究和前沿进展，及时刊载和报道该领域的研究成果 ...
Diabetes technology and therapeutics 影响因子
Did you know?
WebPubMed Central (PMC)链接：PubMed Central 平均审稿速度：网友分享经验：偏慢,4-8周 来源Elsevier官网：平均15.8周 平均录用比例：网友分享经验：较难 在线出版周期： http://impactfactor.cn/5564.html
Web期刊名称：Diabetes Technology & Therapeutics; 期刊名缩写：DIABETES TECHNOL THE; 期刊ISSN：1520-9156; E-ISSN：1557-8593; 2024年影响因子/JCR分区：7.337/Q1; 学科与分区：ENDOCRINOLOGY & METABOLISM - SCIE(Q1) 出版国家或地区：UNITED STATES; 出版周期：Monthly; 出版年份：1999; 年文章数：115; 是否OA ... WebDiabetes Technology & Therapeutics Editor-in-Chief: Satish K. Garg, MD ISSN: 1520-9156 Online ISSN: 1557-8593 Published Monthly Current Volume: 25
WebDiabetes Technology and Therapeutics is listed in a wide range of abstracting and indexing datasets like Scopus, Web of Science and Research.com. A number of leading … WebDiabetes Technology & Therapeutics杂志网站提供期刊影响因子、JCR和中科院分区查询，SCI期刊投稿经验，Impact Factor（IF），官方投稿网址，审稿周期/时间，研究方 …
WebFeb 22, 2024 · Abstracts will be available in the Diabetes Technology & Therapeutics Journal at the start of the ATTD 2024 Conference starts on 22 February 2024. The 14 th ATTD Yearbook, the 2024 Yearbook, ... Professor Moshe Phillip continued, “Diabetes technology is maturing. We must perfect it and make it really accessible in day-to-day …
WebApr 5, 2024 · Diabetes Technology & Therapeutics. Editor-in-Chief: Satish K. Garg, MD. ISSN: 1520-9156 Online ISSN: 1557-8593 Published Monthly Current Volume: 25. Impact Factor: 7.337* *2024 Journal Citation Reports™ (Clarivate, 2024) option chain indiaWebDiabetes Technology & Therapeutics will accept Original Articles, Reviews, and Brief Reports about the use of technology and products to treat, diagnose, and prevent diabetes. Original Articles . 5,000-word limit ; Structured abstract of no more than 250 words ; option chain intcWebJun 29, 2024 · Little is known about the impact of real-time continuous glucose monitoring (rtCGM) on diabetes-related medical costs within the type 2 diabetes (T2D) population. A retrospective analysis of administrative claims data from the Optum Research Database was conducted. Changes in diabetes-related health care resource utilization costs were … option chain kya haiWebDiabetes Technology & Therapeutics. Diabetes Technology & Therapeutics is the official journal of ATTD. Led by Editor-in-Chief Satish K. Garg, MD, Diabetes Technology & Therapeutics is the only peer-reviewed journal providing information on new devices, drugs, drug delivery systems and software for managing patients with diabetes. option chain indicator tradingviewWebJul 21, 2024 · Diabetes Technology & Therapeutics is the only peer-reviewed journal which provides healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of the … option chain live nseWebMar 30, 2024 · JDST covers scientific and clinical aspects of diabetes technology, the development and use of mobile applications and wireless communication, as well as bioengineered tools. Articles cover both basic … option chain live growWebJournal of Diabetes is an international, imminently open access platform for diabetes research, therapeutics, and education. Uniting East and West, researchers and practitioners are invited to submit papers spanning all … option chain live update